NCT00397254View on ClinicalTrials.gov

Two Rizatriptan Prescribing Portions for Treatment of Migraine

PHASE4CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Migraine
Interventions
DRUG

rizatriptan

10mg ODT 27 tablets

DRUG

rizatriptan

10mg ODT 9 tablets

Trial Locations (10)

19107

Thomas Jefferson University Hospital Jefferson Headache Center, Philadelphia

20678

Dhiren Shah, MD, Prince Frederick

27401

PharmQuest, Greensboro

32765

Physician Associates, Oviedo

33039

Dr. B. Abraham, PC, Snellville

49009

Westside Family Medical Center, Kalamazoo

63141

Mercy Health Research / Ryan Headache Center, St Louis

65807

Clinvest, Springfield

91765

Brian Koffman, MD, Diamond Bar

94109

San Francisco Clinical Research Center, San Francisco

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Clinvest

OTHER

NCT00397254 - Two Rizatriptan Prescribing Portions for Treatment of Migraine | Biotech Hunter | Biotech Hunter